About Us

ABOUT US
BHI BIOLOGICS

BHI Biologics is a U.S.-based company in the preliminary stages of producing stem cells, exosomes/extracellular vesicles, and other biologics in our New Jersey headquarters, equipped with a clean room and state-of-the-art technology.

Biological products often represent the forefront of biomedical research and are being studied for their potential future role in medicine.

With nearly 15 years of experience in stem cell research, our team has contributed to the published scientific literature. Our team was the first to publish a safety study on cultured Wharton’s jelly mesenchymal stem cell research published in 2017 in collaboration with our Jamaica clinic.

Our experience in regenerative medicine research has led us to produce high-quality stem cells, exosomes/extracellular vesicles, and other biologics.

We bring the expertise of BHI Therapeutic Sciences and a team of scientists experienced in regenerative medicine research.

WHAT WE DO
BHI BIOLOGICS

BHI Biologics supplies stem cells and exosomes to physicians and
regenerative medicine clinics across the globe. Products are not
available for purchase by individual patients, but our medical team can
collaborate with providers to make the products available to a
licensed physician and clinic in their location.

750

CLIENTS

400

OUR CLIENTS

250

MEMBERS

HIGH-QUALITY CELLS PRODUCED UNDER STRICT QUALITY CONTROLS

LATEST EQUIPEMENT TECHNOLOGY

Brand-new ISO 7 clean room manufactured in the United States. Equipped with top-of-the-line Thermo Fisher Scientific incubators, clinical grade materials, and other equipment.

EXPERIENCED SCIENTISTS

Our team of scientists has been perfecting WJ-MSC research for over a decade. Our team was the first to publish a safety study on cultured Wharton’s jelly mesenchymal stem cell research published in 2017 in collaboration with our Jamaica clinic.

Scientific research